ARCHIVES

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Erbitux Plus Radiation, Chemo, Appears To Provide CRs In A Small Phase II Study

February 23, 2007

Cancer Rates Keep Falling, NCI’s Progress Report Says.

December 7, 2001

FCRF Recompetition Intriguing, Involved Various Possibility

May 9, 1986

NCI Advisory Group Meetings for September

August 29, 1975

In Brief: Ira Kline, NCI researcher, Dead At 69; Massey Recruits Scientists; ACR Awards

October 15, 1993

In Brief: Holleb Named Memorial Distinguished Alumnus; Hankey Appointed DCPC Statistics Branch Chief

September 1, 1989